Investor insights
Sectors invested in
Obesity1
Biotechnology1
Health Care1
Medical1
Life Science1
Therapeutics1
Hepatic Targeted Insulin Therapies1
Nanotechnology1
Oral Protein Delivery1
Type 1 and Type 2 Diabetes1
Funding rounds participated in
$30M sweet spot round size
Most of their 1 investments are in rounds between $30M and $30M
Investor type
Family Investment Office
Basic info
Industry
financial services
Sectors
Managed Assets
Financial Services
Trust Services
Retirement Services
Asset Management
Financial Planning
Advice
Date founded
2005
Investments made
D
Diasome Pharmaceuticals, Inc. raised $30M on July 5, 2017
Investors: JDRF T1D Fund, Medicxi, - and McDonald Partners